Ipsen Manufacturing Ireland
Ireland Updated 9 July 2026
Ipsen Manufacturing Ireland is an API manufacturer based in Ireland. Its GMP standing is certified by EMA. Its most recent recorded inspection, by US FDA, closed on 25 November 2022 as VAI.
2
registered plants
1 with an FDA FEI number
0
filings
across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
3 of 3 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.
Inspection history
- 25 November 2022 VAI US FDA
- 14 June 2018 NAI US FDA
- 8 August 2014 NAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Ireland, Ireland | 3002807392 |
| Dublin 15, Ireland | Not on file |
What they file, and where
Also appears on these molecule pages
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| EMA | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Ipsen Manufacturing Ireland comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 25 November 2022.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates